Nogra Pharma is a Pharmaceutical and Research & Development Company
We Look For Potential
We identify innovative projects that are of therapeutic potential in Immune-Inflammatory-Mediated Diseases through our extensive network of academic partnerships.
We Provide Management & Oversight
We manage each step of a project, from target identification to proof-of-concept clinical studies
We establish fruitful Partnerships
- We establish long and fruitful R&D partnerships both with Universities & Research Institutes to source innovative targets and with Pharma/Biotech companies for the completion of the development process and commercialisation.
- We use outsourcing as a strategic tool in R&D, manufacturing, and distribution while we retain strategic planning and management of CMC, nonclinical, regulatory, and clinical activities, direct interaction with Competent Authorities for R&D plans (FDA, EMA, Local CAs), IP and BD activities.
- We create ad-hoc, project-specific Teams which include Scientists of Academies and Research Institutes, KOLs, ad hoc Consultants, selected worldwide and having project-specific expertise.
Target ID
Lead ID & Preclinical
Formulation Development
Clinical Phase l
Clinical Phase ll
Clinical Phase lll
Market
We Go From Groundbreaking Research To Innovative Developments
Our pipeline transforms the most innovative immuno-inflammatory projects into pharmaceutical realities.
From the “scientific idea” to the market
